Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B

Gastroenterology. 2021 May;160(6):2155-2158.e4. doi: 10.1053/j.gastro.2021.01.009. Epub 2021 Jan 11.

¹ Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
³ BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia, Canada.
⁴ Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: tsteiner@mail.ubc.ca.

No abstract available

Keywords: Antigen-specific; C difficile; CD4 T cell; Fecal Microbiota Transplant; T cell receptor.

Publication types